Ivax, Forest Square Off Over Antidepressant Drug

Law360, New York (March 21, 2006, 12:00 AM EST) -- Firing the opening shot at trial, generic drug maker Ivax Corp. vigorously defended its alleged infringement of the antidepressant Lexapro, asserting that Forest Laboratories’ patent for the blockbuster drug is invalid.

On Monday, the long-simmering patent battle between the two companies officially got underway, as the bench trial began in U.S. District Court for the District of Delaware.

New York-based Forest and its Danish licensing partner H. Lundbeck A/S sued Ivax in 2003, charging the Miami-based subsidiary of Teva Pharmaceuticals Industries Ltd. with infringing on Lexapro’s...
To view the full article, register now.